Reference
- Zee DS. Perspectives on the pharmacotherapy of vertigo. Arch Otolaryngol 1985; 111: 609–12
- Kubicek W G, Anderson WD. Blood flow changes into the dog labyrinthine arteries. Paper presented at the American Academy of Ophthalmology and Otolaryngology. Palmer House, ChicagoUSA October-November, 1967
- Martinez DM. The effects of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol (Stockh) 1972; 29–47, Suppl 305
- Unemoto H, Sasa M, Takaori S, Ito J, Matsuoka I. Inhibitory effect of betahistine on polysynap-tic neurons in the lateral vestibular nucleus. Arch Otorhinolaryngol 1982; 236: 229–36
- Wilmot T J, Menon GN. Betahistine (SERC) in Menieres disease. J Laryngol Otol 1976; 90: 833–40
- Canty P, Valentine J, Papworth SJ. Betahistine in peripheral vertigo. A double-blind, placebo-controlled, cross-over study of SERC versus placebo. J Laryngol Otol 1981; 95: 687–93
- Oosterveld WI. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind, placebo-controlled study. J Laryngol Otol 1984; 98: 37–41
- Oosterveld WJ. Effect of betahistine dihydrochloride on induced vestibular nystagmus: a double blind study. Clin Otolaryngol 1987; 12: 131–5
- Aantaa E. 1988, Data on file
- Pfaltz C R, Matefi T. Menieres disease or syndrome. Menieres disease. International Symposium, Düsseldorf., Vosteen, et al. George Thieme Verlag, Stuttgart 1981; 1–10
- Coleman BH. Menieres disease. Diseases of the ear, nose and throat. 4th ed, Vol. 2., J Ballantyne, J Groves. Butterworths, London 1979; 785–9
- Hart CW. Menieres disease: Terminology and data bank acquisition. Am J Otol 1981; 2: 216–8